Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00825786 · ClinicalTrials.gov registry record · Phase 3
Ultrasound Guided Supraclavicular Nerve Block
A Phase 3 study of Local Anesthetic, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- Phase 3
- Development phase
- 103
- Enrollment target
- 1
- Study location
NCT00825786: Completed Phase 3 study of Local Anesthetic, sponsored by The Cleveland Clinic.
NCT00825786 is a Phase 3 study of Local Anesthetic that has completed, run by The Cleveland Clinic. The registered enrollment target is 103 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00825786, a Phase 3 study of Local Anesthetic, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 103 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test the hypothesis that sequential injection of 1.5% mepivacaine followed 90 seconds later by 0.5% ropivacaine in ultrasound guided supraclavicular block provides a quicker onset and a longer duration of analgesia than an equi-dose mixture of the two local anesthetics.
Primary Outcome
The primary outcomes will be the onset time, onset of surgical block, and duration of analgesia.
Conditions Studied
Interventions
- DRUG Mepivacaine
- DRUG Ropivacaine
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2008-09 |
| Est. Completion | 2010-08 |
| Phase | Phase 3 |
What the finished NCT00825786 record still lists
NCT00825786 is an interventional study that assigns participants to a tested intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Local Anesthetic appearing as the primary indexed condition, and to 2 interventions - of which Mepivacaine is the first listed.
NCT00825786 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT00825786 about?
NCT00825786 is a clinical study titled "Ultrasound Guided Supraclavicular Nerve Block". This study will test the hypothesis that sequential injection of 1.5% mepivacaine followed 90 seconds later by 0.5% ropivacaine in ultrasound guided supraclavicular block provides a quicker onset and a longer duration of analgesia than an equi-dose mixture of the two local anesthetics.
What is the current status of trial NCT00825786?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 103 participants. The study started on 2008-09. Estimated completion is 2010-08.
What conditions does trial NCT00825786 study?
This clinical trial studies the following conditions: Local Anesthetic.
What interventions are being tested in trial NCT00825786?
The interventions under investigation include: Mepivacaine (DRUG), Ropivacaine (DRUG).
Who is sponsoring clinical trial NCT00825786?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00825786 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00825786's enrollment target sits among peer trials
103 1674th of 2000 higher than 325 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04690348 · 103 participants · Phase 2
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- NCT05282277 · 103 participants · Phase 4
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- NCT05566769 · 103 participants · NA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- NCT05834478 · 103 participants · Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia